Ignite Creation Date:
2025-12-24 @ 5:59 PM
Ignite Modification Date:
2026-01-03 @ 10:19 PM
Study NCT ID:
NCT00559468
Status:
COMPLETED
Last Update Posted:
2019-11-25
First Post:
2007-11-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sugammadex After Continuous Infusion of Rocuronium During Sevoflurane and Propofol Anesthesia (P05949; MK-8616-028)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-12-07
Start Date Type:
ACTUAL
Primary Completion Date:
2007-03-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-03-02
Completion Date Type:
ACTUAL
First Submit Date:
2007-11-14
First Submit QC Date:
None
Study First Post Date:
2007-11-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-09-13
Results First Submit QC Date:
None
Results First Post Date:
2019-02-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-13
Last Update Post Date:
2019-11-25
Last Update Post Date Type:
ACTUAL